Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JTX 8064 |
Trade Name | |
Synonyms | JTX-8064|JTX8064 |
Drug Descriptions |
JTX 8064 is an antagonist monoclonal antibody targeting LILRB2, which potentially induces macrophage polarization against tumor cells (PMID: 36780212). |
DrugClasses | LILRB2 Antibody 11 |
CAS Registry Number | NA |
NCIT ID | C178281 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JTX 8064 | JTX 8064 | 0 | 1 |
JTX 8064 + Pembrolizumab | JTX 8064 Pembrolizumab | 0 | 1 |
JTX 8064 + Pimivalimab | JTX 8064 Pimivalimab | 0 | 1 |